Detalhe da pesquisa
1.
Quantitative assay to analyze neutralization and inhibition of authentic Middle East respiratory syndrome coronavirus.
Med Microbiol Immunol
; 213(1): 6, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722338
2.
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
Proc Natl Acad Sci U S A
; 118(28)2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162739
3.
The C-terminus of Sudan ebolavirus VP40 contains a functionally important CXnC motif, a target for redox modifications.
Structure
; 31(9): 1038-1051.e7, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392738
4.
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults.
iScience
; 25(3): 103951, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35224466
5.
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome.
Nat Commun
; 13(1): 4182, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853863
6.
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
Viruses
; 13(8)2021 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452363
7.
Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro.
Mol Ther Nucleic Acids
; 16: 686-697, 2019 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125846